Patient Preferences for Change in Symptoms Associated with Opioid-Induced Constipation

被引:16
作者
Epstein, Robert S. [1 ]
Cimen, Ali [2 ]
Benenson, Hannah [3 ]
Aubert, Ronald E. [1 ]
Khalid, Mona [1 ]
Sostek, Mark B. [4 ]
Salimi, Tehseen [4 ]
机构
[1] Epstein Hlth, Woodcliff Lake, NJ 07677 USA
[2] AstraZeneca, Cambridge, England
[3] Brown Univ, Providence, RI 02912 USA
[4] AstraZeneca, Gaithersburg, MD USA
关键词
Burden; Chronic pain; Constipation; Opioid-induced constipation; Opioids; Patient; Symptoms; INDUCED BOWEL DYSFUNCTION; ORAL MORPHINE; PREVALENCE; US;
D O I
10.1007/s12325-014-0169-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
While opioids have become a standard treatment option for those experiencing moderate to severe chronic pain, side effects of constipation and related symptoms have interfered with their usage in as many as 40-50% of treated patients. Prior research has elucidated the range of these symptoms, but no study has determined which of these symptoms patients most desire improving or whether improving constipation itself by as little as one more bowel movement per week is deemed an important change. We conducted an online patient survey of 513 participants residing in one of six countries who reported having chronic pain, were taking opioids, and experiencing opioid-induced constipation (OIC) to address these questions. Respondents rank ordered their preferences and the following eight symptoms generated > 80% endorsement as important to improve: improvement in having bowel movements without rectal pain, soft stools that are not loose or watery, regular bowel movements, a reduction in rectal straining, relief from feeling bloated, feeling less fear about having OIC when following their opioid medication regime, a desire to worry less overall about having a bowel movement, and with less 'stomach' area pain. When asked 'how important is it you to have 1 more bowel movement per week", over 90% endorsed it was 'somewhat', 'very', or 'extremely important' with nearly 70% (n = 354) endorsing the 'extremely' or 'very important' response options. In multivariate models, being in more overall pain or reporting fewer than 3 bowel movements per week were found to be independent predictors of the importance. These results highlight the notable range of OIC symptoms most desired by patients to improve and demonstrate that bowel movements of only one more per week were important to register a meaningful improvement. The latter is particularly helpful for those assessing the minimal clinically important difference in treating this condition.
引用
收藏
页码:1263 / 1271
页数:9
相关论文
共 16 条
  • [1] Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain
    Allan, L
    Hays, H
    Jensen, NH
    de Waroux, BL
    Bolt, M
    Donald, R
    Kalso, E
    [J]. BRITISH MEDICAL JOURNAL, 2001, 322 (7295): : 1154 - 1158
  • [2] The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1)
    Bell, Timothy J.
    Panchal, Sunil J.
    Miaskowski, Christine
    Bolge, Susan C.
    Milanova, Tsveta
    Williamson, Russell
    [J]. PAIN MEDICINE, 2009, 10 (01) : 35 - 42
  • [3] Brown Randall T, 2006, J Opioid Manag, V2, P137
  • [4] Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation
    Camilleri, M.
    Drossman, D. A.
    Becker, G.
    Webster, L. R.
    Davies, A. N.
    Mawe, G. M.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (10) : 1386 - 1395
  • [5] Strategies to manage the adverse effects of oral morphine: An evidence-based report
    Cherny, N
    Ripamonti, C
    Pereira, J
    Davis, C
    Fallon, M
    McQuay, H
    Mercadante, S
    Pasternak, G
    Ventafridda, V
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (09) : 2542 - 2554
  • [6] Gastrointestinal side effects in chronic opioid users: results from a population-based survey
    Cook, S. F.
    Lanza, L.
    Zhou, X.
    Sweeney, C. T.
    Goss, D.
    Hollis, K.
    Mangel, A. W.
    Fehnel, S. E.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (12) : 1224 - 1232
  • [7] Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review
    Coyne, Karin S.
    LoCasale, Robert J.
    Datto, Catherine J.
    Sexton, Chris C.
    Yeomans, Karen
    Tack, Jan
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2014, 6 : 269 - 281
  • [8] A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease
    Dhingra, Lara
    Shuk, Elyse
    Grossman, Bella
    Strada, Alessandra
    Wald, Emily
    Portenoy, Allison
    Knotkova, Helena
    Portenoy, Russell
    [J]. PALLIATIVE MEDICINE, 2013, 27 (05) : 447 - 456
  • [9] Dorn Spencer, 2014, Am J Gastroenterol Suppl, V2, P31, DOI 10.1038/ajgsup.2014.7
  • [10] Leslie J, 2006, ANESTHESIOLOGY, V105